Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood Stem Cell Transplantation From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies

Sophie Servais, Raphaël Porcher, Marie Robin, Alienor Xhaard, Emeline Masson, Jerome Larghero, Patricia Ribaud, Sarah Abbes, Nathalie Dhedin, Gerard Socie, Regis Peffault de Latour

Blood (2012) 120 (21): 2000.

https://doi.org/10.1182/blood.V120.21.2000.2000

Published: 2012

Journal Articles

Early Development of Immunity to CMV Following Hematopoietic-Stem Cell Transplantation Is Associated with Graft-Versus Leukaemia Effect

Valérie Guérin-El Khourouj, Raphaël Porcher, Sandrine Leveille, Jérôme Le Goff, Béatrice Pédron, PhD, MD, Andre Baruchel, PhD, MD, Jean-Hugues Dalle, PhD, MD, Ghislaine Sterkers, PhD, MD

Blood (2012) 120 (21): 4214.

https://doi.org/10.1182/blood.V120.21.4214.4214

Published: 2012

Journal Articles

Equivalent Outcome Between Reduced Intensity Versus Conventional Myeloablative Conditioning Hematopoietic Stem Cell Transplantation for Patients Older Than 35 Years with Acute Myeloid Leukemia.

Marie Sebert, Raphaël Porcher, Marie Robin, Lionel Ades, MD, PhD, Emmanuel Raffoux, Alienor Xhaard, Nathalie Dhedin, MD, Jerome Larghero, Chantal Himberlin, MD, Alain Delmer, MD, Pierre Fenaux, MD, PhD, Hervé Dombret, MD, PhD, Gérard Socié, MD PhD, Regis Peffault de Latour

Blood (2012) 120 (21): 3103.

https://doi.org/10.1182/blood.V120.21.3103.3103

Published: 2012

Journal Articles

Mycological Diagnosis of Invasive Pulmonary Aspergillosis Should Depend on Both the Underlying Condition and the Neutropenia Status of Patients with Hematologic Malignancies

Anne Bergeron, MD, PhD, Raphaël Porcher, PhD, Annie Sulahian, PhD, Cédrid de Bazelaire, MD, PhD, Karine Chagnon, MD, Claire Lacroix, PhD, Emmanuel Raffoux, MD, Françoise Isnard, MD, Jean-Louis Poirot, PhD, Anne Vekhoff, Claire Bouges-Michel, PhD, Abdellatif Tazi, MD, PhD, Patricia Ribaud

Blood (2010) 116 (21): 1243.

https://doi.org/10.1182/blood.V116.21.1243.1243

Published: 2010

Journal Articles

Major Improvement of Invasive Aspergillosis Outcome Is Not Enough to Improve Overall Survival In Allogeneic Hematopoietic Stem Cell Transplant Recipients: Results From a Single-Center Retrospective Analysis

Géraldine Salmeron, MD, Raphaël Porcher, Anne Bergeron, Marie Robin, Regis Peffault de Latour, Vanderson Rocha, Anna D. Petropoulou, MD, Alienor Xhaard, Annie Sulahian, PhD, Gérard Socié, Patricia Ribaud, MD

Blood (2010) 116 (21): 1244.

https://doi.org/10.1182/blood.V116.21.1244.1244

Published: 2010

Journal Articles

Risk Factors for Late Infections after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Related Donor.

Marie Robin, Raphaël Porcher, Renato De Castro Araujo, Régis Peffault de Latour, Agnès Devergie, Vanderson Rocha, Jérome Larghero, Hélène Espérou, Lionel Adès, Eliane Gluckman, Patricia Ribaud, Jean-Yves Mary, Gérard Socié

Blood (2006) 108 (11): 2848.

https://doi.org/10.1182/blood.V108.11.2848.2848

Published: 2006

Journal Articles

Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation: Presented in part at the Annual Meeting of the American Society of Hematology, Orlando, FL, December 7-11, 2001.

Vanderson Rocha, Rendrik F. Franco, Raphaël Porcher, Henrique Bittencourt, Wilson A. Silva, Jr, Aurelien Latouche, Agnès Devergie, Hélène Espérou, Patricia Ribaud, Gérard Socié, Marco Antonio Zago, Eliane Gluckman

Blood (2002) 100 (12): 3908–3918.

https://doi.org/10.1182/blood-2002-04-1033

Published: 2002

Journal Articles

Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease

Véronique Leblond, Vincent Lévy, Frédéric Maloisel, Bruno Cazin, Jean-Paul Fermand, Jean-Luc Harousseau, Liliane Remenieras, Raphaël Porcher, Martine Gardembas, Gérald Marit, Eric Deconinck, Bernard Desablens, François Guilhot, Guilaine Philippe, Aspasia Stamatoullas, Odile Guibon

Blood (2001) 98 (9): 2640–2644.

https://doi.org/10.1182/blood.V98.9.2640

Published: 2001

Journal Articles

Alternate designs for conduct and analysis of phase I cancer trials

Vincent Lévy, Sarah Zohar, Raphaël Porcher, Sylvie Chevret

Blood (2001) 98 (4): 1275.

https://doi.org/10.1182/blood.V98.4.1275

Published: 2001

NARROW

Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood Stem Cell Transplantation From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies

Early Development of Immunity to CMV Following Hematopoietic-Stem Cell Transplantation Is Associated with Graft-Versus Leukaemia Effect

Equivalent Outcome Between Reduced Intensity Versus Conventional Myeloablative Conditioning Hematopoietic Stem Cell Transplantation for Patients Older Than 35 Years with Acute Myeloid Leukemia.

Mycological Diagnosis of Invasive Pulmonary Aspergillosis Should Depend on Both the Underlying Condition and the Neutropenia Status of Patients with Hematologic Malignancies

Major Improvement of Invasive Aspergillosis Outcome Is Not Enough to Improve Overall Survival In Allogeneic Hematopoietic Stem Cell Transplant Recipients: Results From a Single-Center Retrospective Analysis

Risk Factors for Late Infections after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Related Donor.

Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation: Presented in part at the Annual Meeting of the American Society of Hematology, Orlando, FL, December 7-11, 2001.

Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease

Alternate designs for conduct and analysis of phase I cancer trials

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only